United States · FDA National Drug Code directory
Fexofenadine HCL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73581-010_52d50de4-dca4-33ff-e063-6394a90a1b09
- Product NDC
- 73581-010
- Form
- TABLET
- Composition / generic term
- Fexofenadine HCL
- Labeler
- YYBA Corp
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260101
- Source listing expiry
- 20271231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (73581-010-01) · 73581-010-01
- 60 TABLET in 1 BOTTLE (73581-010-06) · 73581-010-06
- 100 TABLET in 1 BOTTLE (73581-010-10) · 73581-010-10
- 200 TABLET in 1 BOTTLE (73581-010-20) · 73581-010-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →